ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
Nicoletta Colombo(European Society for Medical Oncology), C. Sessa(Ospedale San Giovanni Bellinzona), Andreas du Bois(Kliniken Essen-Mitte), Jonathan A. Ledermann(CRUK Lung Cancer Centre of Excellence), W. Glenn McCluggage(Belfast Health and Social Care Trust), Iain A. McNeish(Imperial College London), Philippe Morice(Institut Gustave Roussy), Sandro Pignata(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), I. L. Ray-Coquard(Centre Léon Bérard), Ignace Vergote(KU Leuven), Thaïs Baert(Kliniken Essen-Mitte), I. Belaroussi(Institut Gustave Roussy), A. Dashora(Maidstone and Tunbridge Wells NHS Trust), Siel Olbrecht(KU Leuven), François Planchamp(Institut Bergonié), Denis Querleu(Institut Bergonié)
Cited by 397Open Access
Abstract
Related Papers
International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm Trial: Two Parallel Randomized Phase III Trials of Adjuvant Chemotherapy in Patients With Early-Stage Ovarian Carcinoma
International Collaborative Ovarian Neoplasm 1 (ICON1)|JNCI Journal of the National Cancer Institute|2003|446